Tempus AI enters collaboration with Institute for Follicular Lymphoma Innovation
Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...
Tempus AI downgraded to Market Perform from Outperform at William Blair
William Blair downgraded Tempus AI (TEM) to Market Perform from Outperform without a price target The firm cites valuation for the downgrade ...